Fig. 2 (abstract A15)From: Meeting Abstracts from the International Burden of Disease Conference 2022The burden (DALYs, ASRs per 100,000) of lung cancer attributed to high fasting plasma glucose in European Region, by sex, in 2019.Back to article page